EMERALD HEALTH THERAPEUTICS CANADA INC has a total of 18 patent applications. Its first patent ever was published in 2019. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are SERVOMED ARZNEIMITTEL GMBH, BEIJING LANDAN PHARMACEUTICAL TECHNOLOGY CO LTD and BEIJING FUKANGREN BIOPHARMACEUTICAL TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | Canada | 7 | |
#3 | United States | 2 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Consumer goods |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Medical purpose containers | |
#4 | Cigarettes |
# | Name | Total Patents |
---|---|---|
#1 | Wagner Christopher | 17 |
#2 | Garabagi Freydoun | 12 |
#3 | Harrison Nancy | 12 |
#4 | Mcbride Andrew | 5 |
#5 | Sahota Hardip | 5 |
#6 | Kadhim Salam A | 4 |
#7 | Harrison Nancy E | 4 |
#8 | Kadhim Salam | 4 |
#9 | Morello Gaetano | 2 |
#10 | Garabagi Freydoum | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020044121A1 | Oral formulations of phenylalanine and cannabinoids | |
WO2020044118A1 | Improved cannabinoid bioavailability | |
CA3110422A1 | Oral formulations of lavender and cannabinoids | |
WO2020044123A1 | Therapeutic combinations of boswellia extract and cannabinoids | |
WO2020044116A1 | Therapeutic combinations of cannabinoids with curcumin | |
WO2020016660A2 | Cannabis cigarette with dose markings | |
WO2019186284A2 | Defined dose cannabis puck | |
US2021000789A1 | Defined dose cannabis pod |